Thaker, A. M.PATEL, URVESHKUMAR DAHYABHAI2018-07-182018-07-182009http://krishikosh.egranth.ac.in/handle/1/5810060663Levofloxacin is a novel third generation fluoroquinolone with broad spectrum antibacterial activity. Use of non-steroidal anti-inflammatory drugs (NSAIDs) are frequently recommended with antibacterials for the treatment of various bacterial infections accompanied by fever and other inflammatory conditions in animals. Ketoprofen (KTP) is an aryl propionic acid derivative, non-selective COX inhibitor NSAID having anti-inflammatory, analgesic and antipyretic properties. In veterinary practice, ketoprofen is used to lower body temperature in animals having fever, to relieve bacteremia and pain in all animals. Pharmacokinetics of an antibacterial drug may change when administered with anti-inflammatory drug or in febrile animals. Despite the great potential for clinical use of levofloxacin, the data on its pharmacokinetics and safety profile in sheep are scarce. The present study was planned to determine the effect of intramuscularly administered ketoprofen (3 mg/kg) and febrile condition (lipopolysaccharide (LPS) induced) on pharmacokinetics of levofloxacin following intravenous, subcutaneous and oral administration (3 mg/kg) in sheep and safety of daily intravenous administration of levofloxacin alone (3 mg/kg) and in combination with intramuscular administration of ketoprofen (3 mg/kg) for five days in sheep by monitoring haematological and blood biochemical profiles.enVETERINARY PHARMACOLOGY & TOXICOLOGYA STUDYThesis